210
Views
13
CrossRef citations to date
0
Altmetric
Original Research

A new approach of ocular nebulization with vitamin B12 versus oxytocin for the treatment of dry eye disease: an in vivo confocal microscopy study

, , , , , , , , , , & show all
Pages 2381-2391 | Published online: 18 Jul 2019

References

  • Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276–283. doi:10.1016/j.jtos.2017.05.00828736335
  • Uchino M, Yokoi N, Uchino Y, et al. Prevalence of dry eye disease and its risk factors in visual display terminal users: the Osaka study. Am J Ophthalmol. 2013;156(4):759–766. doi:10.1016/j.ajo.2013.05.04023891330
  • Vehof J, Kozareva D, Hysi PG, Hammond CJ. Prevalence and risk factors of dry eye disease in a British female cohort. Br J Ophthalmol. 2014;98(12):1712–1717. doi:10.1136/bjophthalmol-2014-30520125185440
  • Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334–365. doi:10.1016/j.jtos.2017.05.00328736337
  • Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol. 2012;130(1):90–100. doi:10.1001/archophthalmol.2011.36422232476
  • Rhee MK, Mah FS. Inflammation in dry eye disease: how do we break the cycle? Ophthalmology. 2017;124(11s):S14–s19. doi:10.1016/j.ophtha.2017.08.02929055357
  • Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15(3):575–628. doi:10.1016/j.jtos.2017.05.00628736343
  • Theodoropoulos DS. Optic neuropathy in vitamin B12 deficiency. Lancet. 1998;352(9122):146–147.
  • Akdal G, Yener GG, Ada E, Halmagyi GM. Eye movement disorders in vitamin B12 deficiency: two new cases and a review of the literature. Eur J Neurol. 2007;14(10):1170–1172. doi:10.1111/j.1468-1331.2007.01824.x17880572
  • Jurkunas UV, Jakobiec FA, Shin J, Zakka FR, Michaud N, Jethva R. Reversible corneal epitheliopathy caused by vitamin B12 and folate deficiency in a vegan with a genetic mutation: a new disease. Eye (Lond). 2011;25(11):1512–1514. doi:10.1038/eye.2011.17721818128
  • Ozen S, Ozer MA, Akdemir MO. Vitamin B12 deficiency evaluation and treatment in severe dry eye disease with neuropathic ocular pain. Graefes Arch Clin Exp Ophthalmol. 2017;255(6):1173–1177. doi:10.1007/s00417-017-3632-y28299439
  • Shetty R, Deshpande K, Ghosh A, Sethu S. Management of ocular neuropathic pain with vitamin B12 supplements: a case report. Cornea. 2015;34(10):1324–1325. doi:10.1097/ICO.000000000000057226266431
  • DeMayo MM, Song YJC, Hickie IB, Guastella AJ. A review of the safety, efficacy and mechanisms of delivery of nasal oxytocin in children: therapeutic potential for autism and prader-willi syndrome, and recommendations for future research. Paediatr Drugs. 2017;19(5):391–410. doi:10.1007/s40272-017-0248-y28721467
  • Guastella AJ, Hickie IB, McGuinness MM, et al. Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research. Psychoneuroendocrinology. 2013;38(5):612–625. doi:10.1016/j.psyneuen.2012.11.01923265311
  • Biyikli NK, Tugtepe H, Sener G, et al. Oxytocin alleviates oxidative renal injury in pyelonephritic rats via a neutrophil-dependent mechanism. Peptides. 2006;27(9):2249–2257. doi:10.1016/j.peptides.2006.03.02916707192
  • Jankowski M, Bissonauth V, Gao L, et al. Anti-inflammatory effect of oxytocin in rat myocardial infarction. Basic Res Cardiol. 2010;105(2):205–218. doi:10.1007/s00395-009-0076-520012748
  • Gumus B, Kuyucu E, Erbas O, Kazimoglu C, Oltulu F, Bora OA. Effect of oxytocin administration on nerve recovery in the rat sciatic nerve damage model. J Orthop Surg Res. 2015;10:161. doi:10.1186/s13018-015-0301-x26466786
  • Rash JA, Aguirre-Camacho A, Campbell TS. Oxytocin and pain: a systematic review and synthesis of findings. Clin J Pain. 2014;30(5):453–462. doi:10.1097/AJP.0b013e31829f57df23887343
  • Dolovich MB, Dhand R. Aerosol drug delivery: developments in device design and clinical use. Lancet. 2011;377(9770):1032–1045. doi:10.1016/S0140-6736(10)60926-921036392
  • Martin AR, Finlay WH. Nebulizers for drug delivery to the lungs. Expert Opin Drug Deliv. 2015;12(6):889–900. doi:10.1517/17425247.2015.99508725534396
  • Pult H, Purslow C, Murphy PJ. The relationship between clinical signs and dry eye symptoms. Eye (Lond). 2011;25(4):502–510. doi:10.1038/eye.2010.22821252949
  • van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol. 1969;82(1):10–14.4183019
  • Hamrah P, Qazi Y, Shahatit B, et al. Corneal Nerve and Epithelial Cell Alterations in Corneal Allodynia: An In Vivo Confocal Microscopy Case Series. Ocul Surf. 2017;15(1):139–151. doi:10.1016/j.jtos.2016.10.00227816571
  • Villani E, Magnani F, Viola F, et al. In vivo confocal evaluation of the ocular surface morpho-functional unit in dry eye. Optom Vis Sci. 2013;90(6):576–586. doi:10.1097/OPX.0b013e318294c18423670123
  • Kheirkhah A, Rahimi Darabad R, Cruzat A, et al. Corneal epithelial immune dendritic cell alterations in subtypes of dry eye disease: a pilot in vivo confocal microscopic study. Invest Ophthalmol Vis Sci. 2015;56(12):7179–7185. doi:10.1167/iovs.15-1743326540656
  • Oliveira-Soto L, Efron N. Morphology of corneal nerves using confocal microscopy. Cornea. 2001;20(4):374–384.11333324
  • Lagali NS, Griffith M, Shinozaki N, Fagerholm P, Munger R. Innervation of tissue-engineered corneal implants in a porcine model: a 1-year in vivo confocal microscopy study. Invest Ophthalmol Vis Sci. 2007;48(8):3537–3544. doi:10.1167/iovs.06-148317652721
  • Okamoto Y, Ishitobi M, Wada Y, Kosaka H. The potential of nasal oxytocin administration for remediation of autism spectrum disorders. CNS Neurol Disord Drug Targets. 2016;15(5):564–577.27071789
  • Patel DV, McGhee CN. In vivo confocal microscopy of human corneal nerves in health, in ocular and systemic disease, and following corneal surgery: a review. Br J Ophthalmol. 2009;93(7):853–860. doi:10.1136/bjo.2008.15061519019923
  • Alhatem A, Cavalcanti B, Hamrah P. In vivo confocal microscopy in dry eye disease and related conditions. Semin Ophthalmol. 2012;27(5–6):138–148. doi:10.3109/08820538.2012.71141623163268
  • Macri A, Scanarotti C, Bassi AM, et al. Evaluation of oxidative stress levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15 % and vitamin B12 eye drops. Graefes Arch Clin Exp Ophthalmol. 2015;253(3):425–430. doi:10.1007/s00417-014-2853-625398660
  • Romano MR, Biagioni F, Carrizzo A, et al. Effects of vitamin B12 on the corneal nerve regeneration in rats. Exp Eye Res. 2014;120:109–117. doi:10.1016/j.exer.2014.01.01724486457
  • Yu CZ, Liu YP, Liu S, Yan M, Hu SJ, Song XJ. Systematic administration of B vitamins attenuates neuropathic hyperalgesia and reduces spinal neuron injury following temporary spinal cord ischaemia in rats. Eur J Pain. 2014;18(1):76–85. doi:10.1002/j.1532-2149.2013.00390.x24038589
  • Okada K, Tanaka H, Temporin K, et al. Methylcobalamin increases Erk1/2 and Akt activities through the methylation cycle and promotes nerve regeneration in a rat sciatic nerve injury model. Exp Neurol. 2010;222(2):191–203. doi:10.1016/j.expneurol.2009.12.01720045411
  • Muller LJ, Marfurt CF, Kruse F, Tervo TM. Corneal nerves: structure, contents and function. Exp Eye Res. 2003;76(5):521–542.12697417
  • Thibonnier M, Conarty DM, Preston JA, Plesnicher CL, Dweik RA, Erzurum SC. Human vascular endothelial cells express oxytocin receptors. Endocrinology. 1999;140(3):1301–1309. doi:10.1210/endo.140.3.654610067857
  • Spangelo BL, deHoll PD, Kalabay L, Bond BR, Arnaud P. Neurointermediate pituitary lobe cells synthesize and release interleukin-6 in vitro: effects of lipopolysaccharide and interleukin-1 beta. Endocrinology. 1994;135(2):556–563. doi:10.1210/endo.135.2.80338028033802
  • Williams KI, El Tahir KE. Effects of uterine stimulant drugs on prostacyclin production by the pregnant rat myometrium. I. Oxytocin, bradykinin and PGF2 alpha. Prostaglandins. 1980;19(1):31–38.6992222
  • Garrido-Urbani S, Deblon N, Poher AL, et al. Inhibitory role of oxytocin on TNFalpha expression assessed in vitro and in vivo. Diabetes Metab. 2018;44(3):292–295. doi:10.1016/j.diabet.2017.10.00429129540
  • Gibbs DM, Vale W, Rivier J, Yen SS. Oxytocin potentiates the ACTH-releasing activity of CRF(41) but not vasopressin. Life Sci. 1984;34(23):2245–2249.6328161
  • Boyd JG, Gordon T. Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury. Mol Neurobiol. 2003;27(3):277–324. doi:10.1385/MN:27:3:27712845152
  • Johnson EO, Charchanti A, Soucacos PN. Nerve repair: experimental and clinical evaluation of neurotrophic factors in peripheral nerve regeneration. Injury. 2008;39(Suppl 3):S37–S42. doi:10.1016/j.injury.2008.06.015
  • Hawley D, Tang X, Zyrianova T, et al. Myoepithelial cell-driven acini contraction in response to oxytocin receptor stimulation is impaired in lacrimal glands of Sjogren’s syndrome animal models. Sci Rep. 2018;8(1):9919. doi:10.1038/s41598-018-28227-x29967327
  • Arrowsmith S, Wray S. Oxytocin: its mechanism of action and receptor signalling in the myometrium. J Neuroendocrinol. 2014;26(6):356–369. doi:10.1111/jne.1215424888645
  • Chiou GC, Shen ZF, Zheng YQ. Systemic absorption of oxytocin and vasopressin through eyes in rabbits. J Ocul Pharmacol. 1991;7(4):351–359.1809793
  • Willcox MDP, Argueso P, Georgiev GA, et al. TFOS DEWS II tear film report. Ocul Surf. 2017;15(3):366–403. doi:10.1016/j.jtos.2017.03.00628736338
  • Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res. 2004;78(3):409–416.15106920
  • Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea. 1998;17(6):584–589.9820935
  • Hamrah P, Dana MR. Corneal antigen-presenting cells. Chem Immunol Allergy. 2007;92:58–70. doi:10.1159/00009925417264483